Northern Trust
LYRA

Northern Trust’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Northern Trust’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,653
Closed -$42K – 4458
2025
Q1 		$42K Buy
6,653
+927
+16% +$8.67K ﹤0.01% 4250
2024
Q4 		$59.1K Buy
5,726
+2,060
+56% +$22.7K ﹤0.01% 4244
2024
Q3 		$47.1K Buy
3,666
+1,989
+119% +$29.2K ﹤0.01% 4224
2024
Q2 		$23.2K Buy
1,677
+467
+39% +$52.8K ﹤0.01% 4319
2024
Q1 		$376K Sell
1,210
-21
-2% -$5.59K ﹤0.01% 3656
2023
Q4 		$323K Buy
1,231
+91
+8% +$16.5K ﹤0.01% 3702
2023
Q3 		$223K Buy
1,140
+546
+92% +$97.7K ﹤0.01% 3769
2023
Q2 		$122K Sell
594
-3
-0.5% -$417 ﹤0.01% 3983
2023
Q1 		$60K Hold
597
– – ﹤0.01% 4216
2022
Q4 		$93.7K Hold
597
– – ﹤0.01% 4108
2022
Q3 		$149K Hold
597
– – ﹤0.01% 3987
2022
Q2 		$169K Buy
+597
New +$163K ﹤0.01% 3989
2021
Q2 		– Sell
-1,289
Closed -$746K – 4617
2021
Q1 		$746K Sell
1,289
-71
-5% -$44.4K ﹤0.01% 3693
2020
Q4 		$775K Buy
1,360
+382
+39% +$215K ﹤0.01% 3605
2020
Q3 		$547K Sell
978
-59
-6% -$36.7K ﹤0.01% 3587
2020
Q2 		$587K Buy
+1,037
New +$758K ﹤0.01% 3510

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust's LYRA Position: Q2 2025 in Review

Northern Trust sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 6,653 shares — an estimated $42K sold.

Northern Trust first reported a position in LYRA in Q2 2020 and held it in 16 quarters. The position peaked at $775K in Q4 2020. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Northern Trust reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 6,653 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $42K.
  • Northern Trust first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 16 quarters.
  • Northern Trust's LYRA THERAPEUTICS INC position peaked at $775K in Q4 2020.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.